tiprankstipranks
AnaptysBio price target lowered to $36 from $90 at Guggenheim
PremiumThe FlyAnaptysBio price target lowered to $36 from $90 at Guggenheim
1M ago
AnaptysBio price target lowered to $40 from $56 at Wells Fargo
Premium
The Fly
AnaptysBio price target lowered to $40 from $56 at Wells Fargo
1M ago
AnaptysBio downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
AnaptysBio downgraded to Neutral from Buy at H.C. Wainwright
1M ago
AnaptysBio trading halted, news pending
PremiumThe FlyAnaptysBio trading halted, news pending
1M ago
AnaptysBio downgraded to Neutral from Buy at BTIG
Premium
The Fly
AnaptysBio downgraded to Neutral from Buy at BTIG
2M ago
AnaptysBio price target lowered to $66 from $75 at JPMorgan
Premium
The Fly
AnaptysBio price target lowered to $66 from $75 at JPMorgan
2M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
3M ago
H.C. Wainwright still ‘optimistic’ on Phase 2 data for AnaptysBio’s rosnilimab
Premium
The Fly
H.C. Wainwright still ‘optimistic’ on Phase 2 data for AnaptysBio’s rosnilimab
3M ago
AnaptysBio weakness on competitor news a buying opportunity, says Guggenheim
Premium
The Fly
AnaptysBio weakness on competitor news a buying opportunity, says Guggenheim
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100